PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Worst Case Consideration, page-11

  1. 285 Posts.
    lightbulb Created with Sketch. 46
    Doing a deal that doesn't reflect our true value.
    As mentioned and researched on here by many OA
    is a growing unmet medical need that effects millions worldwide,and a cost to the healthcare system due to the disease not to mention the current treatment and what that creates as we all know is out of control.
    What else is out there that is cost effective- safe we are simply in the process of ticking the boxes for the FDA,they also need a drug sooner rather than later to treat OA,just look at the statistics with prescription drugs and the damage they cause its mind blowing.
    Big Pharma's know all this and I bet my Balls they are wanting to get on board,patience is key its hard for everyone but just wait and see what happens i feel that Paradigm is playing there cards very well you may all be very pleasantly surprised,let's hope so.
    GO PARADIGM

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.